- d-Lysergic acid diethylamide bitartrate
- d-Lysergic acid dimethylamide
- d-Lysergic acid morpholide, tartaric acid salt
- 639-46-3Morphinan-3,6-diol,7,8-didehydro-4,5-epoxy-17-methyl- (5a,6a)-, 17-oxide
- 63948-92-5Methanone,bis[4-(3-aminophenoxy)phenyl]-
- 63950-87-8RALUFON (R) NO 14
- 63954-77-8Benzaldehyde,3,5-difluoro-2-hydroxy-
- 63956-26-3Benzamide,2,2'-dithiobis[N-decyl- (9CI)
- 639-58-7Stannane,chlorotriphenyl-
- 63958-90-7Thymulin
- 63963-40-64-Quinazolinamine,2-(methylthio)-
- 63966-96-1Benzoic acid,3-amino-4-chloro-, 2-(dodecyloxy)-1-methyl-2-oxoethyl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
d-Lysergic acid morpholide, tartaric acid salt |
EINECS | N/A |
| CAS No. | 63938-26-1 | Density | g/cm3 |
| PSA | 163.63000 | LogP | -0.35040 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C24H29N3O8 | Boiling Point | 604.1°Cat760mmHg |
| Molecular Weight | 487.5024 | Flash Point | 319.2°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intravenous route. Human systemic effects by ingestion: central nervous system effects. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
d-Lysergic acid morpholide,tartaric acid salt; |
d-Lysergic acid morpholide, tartaric acid salt Chemical Properties
Empirical Formula of d-Lysergic acid morpholide, tartaric acid salt (CAS NO.63938-26-1): C24H29N3O8
Molecular Weight: 487.5024 g/mol
Flash Point: 319.2 °C
Enthalpy of Vaporization: 89.84 kJ/mol
Boiling Point: 604.1 °C at 760 mmHg
Vapour Pressure: 1.52E-14 mmHg at 25 °C
Structure of d-Lysergic acid morpholide, tartaric acid salt (CAS NO.63938-26-1):
.png)
Product Categories of d-Lysergic acid morpholide, tartaric acid salt (CAS NO.63938-26-1): Drug / Therapeutic Agenta;Human Data
d-Lysergic acid morpholide, tartaric acid salt Toxicity Data With Reference
| 1. | orl-hmn TDLo:1 µg/kg:CNS | JPETAB Journal of Pharmacology and Experimental Therapeutics. 120 (1957),340. | ||
| 2. | ivn-mus LD50:55.5 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 120 (1957),340. | ||
| 3. | ivn-cat LDLo:6400 µg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 120 (1957),340. | ||
| 4. | ivn-rbt LDLo:400 µg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 120 (1957),340. |
d-Lysergic acid morpholide, tartaric acid salt Safety Profile
Poison by intravenous route. Human systemic effects by ingestion: central nervous system effects.
d-Lysergic acid morpholide, tartaric acid salt Specification
d-Lysergic acid morpholide, tartaric acid salt ,its cas register number is 63938-26-1. It also can be called Ergoline-8-beta-carboxylic acid, 9,10-didehydro-6-methyl-, morpholide, tartaric acid salt .
What can I do for you?
Get Best Price
